Zymergen: Zymergen Investors Mostly Advance Claims Against Venture Funds
SoftBank Group Corp. units and two other venture capital funds must face Zymergen Inc. investors' claims that they are responsible for misleading IPO papers before the biological manufacturing company imploded, a federal court ruled.
Read full article »
Zymergen is a California-based biotechnology company that designs and produces molecules, microbes and materials for agriculture, packaging and manufacturing industries.
Read more